To embed, copy and paste the code into your website or blog:
On January 20, 2021, Health Care Without Harm (HCWH) Europe and 12 other health, environment, and justice organizations sent a letter to Bjorn Hansen, Executive Director of the European Chemicals Agency (ECHA) “seeking clarifications on both the applicable legal framework and risk management measures in place, for nano/biocidal-treated articles in the context of the current COVID-19 pandemic.” The letter states that “[a]s a result of laboratory tests supposedly showing antiviral activity against a range of viruses, the use of biocides/nanoparticles to combat SARS-CoV-2 transmission (particularly silver) is rapidly growing.” According to the letter, the European Union (EU) market currently includes products such as face masks treated with silver, zinc oxide, or copper nanoparticles; “anticovid” paper containing nanostructured zinc-silver; and nanosilver-containing surface disinfectants. The letter states t
Abstract:
On January 20, 2021, Health Care Without Harm (HCWH) Europe and 12 other health, environment, and justice organizations sent a letter to Bjorn Hansen, Executive Director of the European Chemicals Agency (ECHA) seeking clarifications on both the applicable legal framework and risk management measures in place, for nano/biocidal-treated articles in the context of the current COVID-19 pandemic.
January 26th, 2021
Health, Environment, and Justice Organizations Seek Clarification from ECHA on Nano and Biocidal-Treated Products
On January 20, 2021, Health Care Without Harm (HCWH) Europe and 12 other health, environment, and justice organizations sent a letter to Bjorn Hansen, Executive Director of the European Chemicals Agency (ECHA) seeking clarifications on both the applicable legal framework and risk management measures in place, for nano/biocidal-treated articles in the context of the current COVID-19 pandemic. See https://noharm-europe.org/documents/important-questi